Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Biocon secures global rights to biosimilar adalimumab | The Pharmaletter
Biocon surges 7% post-Q4 nos; should you buy now or wait for correction ...
Biocon Share Soars as Arm Acquires Commercialisation of Biosimilars ...
Biocon stock settles 5% higher after US drug regulator clears Bengaluru ...
Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore ...
Biocon Careers 2024: Hiring for IT - Fresher - Freshershunt
Biocon Biologics secures USFDA approval for Bosaya and Aukelso ...
Biocon Secures Rs 4,150 Cr Through QIP to Buy Out Viatris Stake in ...
Biocon confirms sale of 80 lakh Syngene Intl shares for ₹686 crore via ...
USFDA concludes inspection at Biocon Biologics Bengaluru facilities
Serum arm to double investment in Biocon unit | Company Business News
Indian Biopharmaceutical Company Biocon Announces Opening Of First ...
Biocon Biologics receives EU GMP certification for its new biologics ...
Biocon QIP: Firm sets floor price of ₹340.2 per share for ₹4,500 crore ...
Biocon to develop, manufacture and supply chronic weight management ...
Indian drug maker Biocon opens first manufacturing plant in US
Biocon Biologics – Multiple Positions for Regulatory Affairs
Biocon Biologics launches product in US for autoimmune diseases, ETPharma
Biocon Biologics Secures Market Entry Date for Yesafili™, an ...
Legacy - Biocon - Global Biopharmaceutical company
Biocon Biologics on LinkedIn: #nationalbioeconomyshowcase2024
India's Biocon Biologics launches biosimilar for AbbVie's Humira in US ...
A Century of Insulins - Biocon Biologics - Global Biopharmaceutical company
Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base ...
Biocon Biologics’ Johor Bahru Facility Receives FDA VAI Classification ...
Biocon Biologics Concludes Integration of Acquired Biosimilars Business ...
Biocon Opens Its First U.S. Manufacturing Facility in New Jersey to ...
Biocon Limited – The Pharmaceutical Giant With A Gentle Heart | Growfers
Biocon Limited - Transforming Healthcare. Transforming Lives
Biocon biosimilar plant criticized again by the FDA | FiercePharma
Biocon Biologics Opens North America Headquarters in New Jersey’s ...
Manufacturing Locations - Biocon
Biocon R&D Centre - INI Design Studio
Biocon Pharma Limited Is Hiring for Production, Engineering & Packing ...
biocon
Biocon Biologics Scores FDA Approval—A Biosimilar Shake-Up for Amgen ...
Biocon completes $3 34 billion acquisition of viatris s biosimilar ...
Biocon Biologics gets EMA Committee positive opinion for Yesafili
Biocon Biologics Settles Patent Issue; Paves Way for Launch of ...
Biocon Diabetes Drug: Biocon launches diabetes, obesity management drug ...
Biocon shares down as board approves biologics unit merger in $5.5 ...
Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New ...
Biocon Biologics collaborates with RSSDI to expand access to its ...
Biocon Announces New NDC for its Lantus Biosimilar - 340B Report
Biocon Biologics | PSUK
Biocon appoints MB Chinappa as CFO of Biocon Biologics; to be part of ...
Biocon India Logo
S&P Global upgrades Biocon Biologics to ‘BB+’ Outlook revised to Stable ...
Biocon banks on weight-loss drugs, raises stake in biosimilar arm ...
Biocon Biologics Ltd., a subsidiary of Biocon Ltd. announced that it ...
Biocon Merges Biocon Biologics in $5.5 Billion Deal to Strengthen ...
Biocon Biologics’ new monoclonal antibodies manufacturing facility ...
La FDA vuelve a poner bajo su punto de mira a Biocon
Biocon Biologics expands biosimilar insulin portfolio with USFDA nod of ...
Biocon Biologics: Biocon completes $3.34 billion acquisition of Viatris ...
Biocon News: Biocon Latest News, Biocon Today news, Biocon Breaking ...
Biocon merger with Biocon Biologics: What does the $5.5 billion ...
Research & Development - Biocon - Global Biopharmaceutical company
Biocon Biologics marks one year as global biosimilars enterprise ...
Biocon Biologics Yesafili gets Health Canada nod for eye diseases
Biocon Biologics and Civica expand partnership with launch of Insulin ...
Biocon raises ₹4,150 crore via QIP issue on strong investor demand ...
Biocon Biologics partners with Civica to expand Insulin Aspart access ...
Biocon Biologics – Walk-In Drive on 25th Sep’ 2022 for M.Sc / B.Sc / M ...
Biocon Biologics Scales Up Insulin Access in Malaysia - Global Pharma
Biocon
USFDA gives nod to Biocon Biologics' biosimilar to treat Crohn’s ...
Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis ...
Biocon Biologics Report the P-III Study Positive Results of Yesintek ...
Biocon Limited - Walk-in for Freshers on 3rd Feb 2025 - Pharma Walks
Biocon Raises ₹4,150 Crore Via QIP, To Buy Viatris Stake In Biocon ...
Biocon biosimilar plant criticized again by the FDA | Fierce Pharma
Biocon Biologics IPO Plans Under Review As Parent Considers Merger Option
Biocon CFO's Departure Causes Decline in Company's Shares - CEOWORLD ...
Biocon gets US FDA nod for its 1st interchangeable biosimilar insulin ...
Biocon kicks off new era with acquisition of Viatris’ biosimilars
Malaysian Health Ministry extends Biocon Biologics insulin contract for ...
Biocon Biologics gets EU approval for two Denosumab biosimilars ...
Biocon launches QIP to raise ₹4,500 crore | Medial
Biocon Biologics 完成其在约 120 个国家/地区所收购的生物仿制药业务的整合-美通社PR-Newswire
Oncology Biosimilars: Biocon to Launch Keytruda Biosimilars at JPM 2026 ...
Biocon on LinkedIn: Biocon starts new clinical study to evaluate ...
Biocon Biologics gets EU approval for 2 drugs to treat bone cancer ...
Stories - Biocon Biologics
Biocon gets US FDA approval for new facility in Bengaluru
Biocon Biologics on LinkedIn: Biocon Biologics Continues to Expand ...
Biocon gets 8 observations from USFDA after inspection of Malaysia ...
Biosimilars growth props up Biocon Q2 PAT by 168% to Rs 126 crore ...
Biocon denies plans to sell $1.5 billion generic API business - The ...
Biocon Biologics, Viatris get USFDA nod for 1st interchangeable ...
Biocon stake in Hinduja Renewables Two: Biocon To Buy 26% Stake In ...
MediCircle | Biocon
Biocon inaugurates first US manufacturing facility in New Jersey
Biocon: Leading Biopharmaceutical Company in India
Top 13 Core Companies for Biomedical Engineers in India
Branding Asia’s premier biotechnology company - TSK Design
240 Biopharmaceuticals Stock Photos, High-Res Pictures, and Images ...
CBI arrests Joint drug controller for allegedly taking Rs. 4 lakh bribe ...
FDA issues complete response letter for Biocon’s Insulin-R application ...
Biocon's insulin glargine gets Japanese approval
Biocon, Mylan wins patent case for insulin device against Sanofi in the ...
Biocon’s biosimilar Insulin Glargine to be listed on Express Scripts ...
Vaccine access, biosimilars growth to boost Biocon’s earnings outlook ...
Diabetes: Biocon, Mylan launch insulin biosimilar in Australia, ET ...
)
)
)
)
)
